Advertisement

Topics

Companies Related to "Study of Individuals and Families at High Risk for Cancer" [Most Relevant Company Matches] RSS

18:35 EST 15th February 2019 | BioPortfolio

Here are the most relevant search results for "Study of Individuals and Families at High Risk for Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Study Individuals Families High Risk Cancer" Companies 1–25 of 8,900+

Extremely Relevant

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.


Relevant

VisionGate, Inc.

VisionGate, Inc. is led by Dr. Alan Nelson, physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. VisionGate offers the first automated 3D cell imaging platform, the Cell-CT, which computes high-resolution 3D biosignatures f...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...


Oncimmune (USA) LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...

Oncimmune LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...

GiveForward and Lung Cancer Alliance

GiveForward is the leading crowdfunding site focused on helping families and friends raise money to help offset a loved one’s medical bills. Co-founded in 2008 by Desiree Vargas Wrigley and Ethan Austin, GiveForward has raised over 48 million dollars and helped thousands of families across the country. The Lung Cancer Alliance is the only natio...

HealthPlanOne

Founded in 2005, HealthPlanOne offers the broadest portfolios of health plans from top-rated carriers available to individuals, families and Medicare recipients. For more information, visit HealthPlanOne for individuals and families; and Medicare Solutions for Medicare beneficiaries.

Cold Genesys Inc.

Cold Genesys, Inc. is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop CG0070 from BioSante Pharmaceuticals. CG0070 is currently under investigation in a Phase II, single-arm, open-label, pivotal study (BOND II) for patient...

AT-RISK International, LLC

Founded by experts with law enforcement, military and intelligence backgrounds, AT-RISK International, LLC provides security training, protection, threat analysis, consulting and investigations worldwide. Established on the philosophy of proactive security, AT-RISK specializes in assessment and protection based on advance research, analysis and preparation...

Oncimmune Holdings plc

Oncimmune is a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology. Oncimmune has pioneered the development of autoantibody tests that can detect cancer four years or more before diagnosis and can be applied to a wide range of solid tumor types. The Company's first product, EarlyCDT-Lung,...

Liberty Healthcare Corporation

Liberty Healthcare Corporation (www.libertyhealthcare.com) has provided specialized and customized programs for mentally ill individuals in the criminal justice system for over 25 years. It is a recognized expert in the management of high risk, challenging populations in secure settings. Liberty currently operates the California Conditional Release Program...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

Prenetics

Prenetics is a leading genetic testing/digital health company headquartered in Hong Kong and London, with offices in 10 countries globally. They empower individuals with valuable health information. With a simple saliva sample, individuals can discover how their genes affect their diet, drug response, disease and cancer risk. This information enables peopl...

Breastcancer.org

Breastcancer.org is the #1 online resource for breast health and breast cancer information and support, with more than 6,000 pages of medically vetted content and a vibrant peer support community. Breastcancer.org, a nonprofit organization, helps individuals and families understand, interpret and act upon the most reliable and up-to-date breast cancer information so they can make the best decision...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

The Bonnie J. Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, su...

Bonnie J. Addario Lung Cancer Foundation (ALCF)

The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, ind...

Signet Laboratories Incorporated

Signet Laboratories, Inc is a medical biotechnology company focused in fields of cancer and infectious disease(Sepsis). Signet has developed proprietary antibody systems for the detection and management of breast and prostate cancer and Sepsis. Signet's patented technology will provide for determining risk in "normal patients who may be at increased risk for developing cancer at a time when proac...

CellMax Life

CellMax Life, Inc. is a precision cancer blood-testing company providing comprehensive, personalized multi-biomarker technology platforms for genetic cancer risk assessment, early detection and personalized treatment of cancer. CellMax Life’s products include CellMax-DNA Genetic Cancer Risk Test, CellMax-LBx Liquid Biopsy, and CellMax-CRC Colorectal C...

Bonnie J Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, education, early detection, genetic testing, drug discovery and patient-focused outcomes. The Foundation’s commitment to lung cancer patients is to col...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes support for physicians, as well as genetic counseling as part of every order. Color’s goal is to expand physician-supported access to genetic information for breast and ovarian ...

Nagourney Cancer Institute

The Nagourney Cancer Institute is a clinical research center that has pioneered the study of human tumor tissue for individualized cancer patient drug selection and has facilitated cancer drug discovery.

The CEO Roundtable on Cancer

The CEO Roundtable on Cancer was founded in 2001, when former President George H.W. Bush challenged a group of executives to "do something bold and venturesome about cancer within your own corporate families." The CEOs responded with the CEO Cancer Gold Standard encouraging its widespread adoption in workplaces across the country. For more information on t...

Summex Health Management

Summex is a national provider of health management services for large-scale employers. Our wellness programs are proven proactive tools that:Help employees avoid preventable illnesses & measurably improve their health Increase worksite productivity & reduce absenteeism Tangibly reduce health care costsSummex helps businesses by developing, implementing and managing comprehensive wellness programs ...

Kendall Capital Management (KCM)

Established in 2002, Kendall Capital Management (KCM) is an independently registered investment services firm located in Rockville, Maryland. KCM was founded by CEO Clark Kendall, who has over 29 years of financial knowledge and experience. KCM employs certified CFAs, AEPs and CFPs, and offers unbiased, fee-only wealth management planning to a clientele...


More From BioPortfolio on "Study of Individuals and Families at High Risk for Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks